Larvol Delta - AVEO-Oncology-an-LG-Chem-company-Announces-Completion-of-the-First-Interim-Analysis-in-the-Global-Phase-3-FIERCEHN-Study

ficlatuzumab (AV-299) - AVEO Oncology

https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-announces-completion-of-the-first-interim-analysis-in-the-global-phase-3-fierce-hn-study-302691274.html

Feb 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next